pharma-company /Medicinal products /Active ingredients

Rx · PZN 07001451, 09002555

LEVODOPA-Benserazid-ratiopharm 50 mg/12,5 mg tablets

German trade nameLEVODOPA Benserazid-ratiopharm 50 mg-12,5 mg Tabletten

Active ingredientLevodopa and decarboxylase inhibitorSubstance (DE)Levodopa und Decarboxylasehemmer*Pharmaceutical formTablets

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Ambient max. 25 °C

Average purchase price (B2B)

~ €5

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for LEVODOPA-Benserazid-ratiopharm 50 mg/12,5 mg tablets.

Review purchasing terms

LEVODOPA-Benserazid-ratiopharm 50 mg/12,5 mg tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Tablets. 2 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.


Pack sizes · 2 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
070014510.00.0~ €3
090025550.00.0~ €6

LEVODOPA-Benserazid-ratiopharm 50 mg/12,5 mg tablets was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 2 recorded PZNs.